Stop STALLING Act

S. 1095

This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.

Learn about this bill’s status and read its full summary in the Pocket Congress app.

Open in the Pocket Congress app
Download on the App Store

Scan to open this page in Pocket Congress